---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-024167"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2025-11-19T23:59:59+00:00"
generated_at: "2026-05-16T18:23:01.623335+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# NanoVibronix to rebrand as ENvue Medical, focus on enteral-feeding navigation platform

## Summary
- ENvue feeding-tube placement system identified as core growth platform; 38 hospitals already using it.
- U.S. enteral-feeding devices market projected at ~$1.8B by 2030; ENvue is 510(k)-cleared for adults.
- Company planning name change to ENvue Medical and new NASDAQ ticker symbol.
- Exploring strategic alternatives (partnerships/divestitures) for legacy PainShield and UroShield technologies.
- CEO Doron Besser (appointed June 2025) outlines multi-phase roadmap including pediatric, imaging, and vascular applications.

## SEC filing metadata
- accession: 0001493152-25-024167
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2025-11-19T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315225024167/0001493152-25-024167-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315225024167/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-024167
- JSON: https://secwatch.observer/filing/0001493152-25-024167.json
- Plain text: https://secwatch.observer/filing/0001493152-25-024167.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.